New Therapeutic for Glioblastoma, the Most Lethal Form of Brain Cancer: 2023 WARF Innovation Awards

University of Wisconsin-Madison Asst. Prof. Mahua Dey specializes in the surgical management of brain and spinal cord tumors. She partnered with Jacques Galipeau, Marilyn Anderson Prof. of Oncology and an expert in cancer immunotherapy, to develop a vaccine to treat glioblastomas, a lethal form of brain cancer. The vaccine uses potent immune stimulators called fusokines to increase the development of T cells, the body’s natural disease fighters, and recruit them to the brain.
To disclose your invention visit:
warf.org/disclose
To license a WARF technology visit:
warf.org/comme...

[@tikigodsrule2317]

Always a breakthrough but never available. Come on FDA its been 15 years since TMZ was approved.

[@janetmyers3729]

My sister was diagnosed 8 months ago. She chose standard of care following surgery. So far no recurrence. When might human trials begin?

[@dcgorandom]

May I know if that's a kind of cell and gene therapy? Like CAR-T?

[@libbyland9144]

Where do you find out about this?